Interaction of Probenecid with the Breast Cancer Resistance Protein Transporter (BCRP/ABCG2)

E-ISSN： 1875-628x|3|4|236-241

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.3, Iss.4, 2006-05, pp. : 236-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structure and Function of the Human Breast Cancer Resistance Protein (BCRP/ABCG2)

Current Drug Metabolism, Vol. 11, Iss. 7, 2010-09 ,pp. : 603-617

Bentham Science Publishers

Access to resources Recommend Favorite

Interaction of Isoflavones with the BCRP/ABCG2 Drug Transporter

Current Drug Metabolism, Vol. 16, Iss. 2, 2015-01 ,pp. : 124-140

Bentham Science Publishers

Access to resources Recommend Favorite

Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor

By Yeboah D. Sun M. Kingdom J. Baczyk D. Lye S.J. Matthews S.G. Gibb W.

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 12, 2006-12 ,pp. : 1251-1258

NRC Research Press

Access to resources Recommend Favorite

Acyclovir is a substrate for the human breast cancer resistance protein (BCRP/ABCG2): implications for renal tubular transport and acyclovir-induced nephrotoxicity

By Gunness Patrina Aleksa Katarina Koren Gideon

Canadian Journal of Physiology and Pharmacology, Vol. 89, Iss. 9, 2011-07 ,pp. : 675-680

NRC Research Press

Access to resources Recommend Favorite

Lack of Improvement of Oral Absorption of ME3277 by Prodrug Formation Is Ascribed to the Intestinal Efflux Mediated by Breast Cancer Resistant Protein (BCRP/ABCG2)

By Kondo Chihiro Onuki Reiko Kusuhara Hiroyuki Suzuki Hiroshi Suzuki Michiko Okudaira Noriko Kojima Maho Ishiwata Kazuya Jonker Johan W. Sugiyama Yuichi

Pharmaceutical Research, Vol. 22, Iss. 4, 2005-04 ,pp. : 613-618

Springer Publishing Company

Access to resources Recommend Favorite